ArticleJACC. Advances2025
Physicians' Perspectives on a Best Practice Alert to Improve Guideline-Directed Medical Therapy in Heart Failure.
Article in JACC. Advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundMineralocorticoid receptor antagonists (MRAs) are disease-modifying agents indicated for heart failure (HF) that can augment diuresis and treat hypokalemia but are underutilized. Prescribing MRAs instead of potassium supplements to treat hypokalemia in the setting of HF could increase the use of MRAs. A best practice alert (BPA) in the electronic medical record that suggests ordering an MRA instead of potassium supplementation for a HF patient with hypokalemia could facilitate this.
objectivesThis study sought to examine perspectives of primary care physicians on MRA utilization and BPA usefulness and to develop a novel conceptual model for guiding future BPA development.
methodsWe conducted one-on-one semistructured interviews with primary care physicians until we reached thematic saturation to understand facilitators and barriers of MRA prescription, BPA usage, and our specific BPA. Two coders independently reviewed each interview transcript using directed content analysis. Codes were collated into subthemes and themes.
resultsWe interviewed 10 participants. We mapped our themes onto the Capability, Opportunity, Motivation, Behavior (COM-B) model, a well-established model that focuses on influential factors of behavior change. Based on these findings, we created a BPA-specific framework that reflects the necessary components for changing medication-prescribing behavior.
conclusionsWe generated a conceptual model to guide development of future BPAs focused on changing medication-prescribing practice based on the COM-B model, using MRAs as a prototype for development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.